The only research consortium dedicated to assessing biologics, including biosimilars
BBCIC is a non-profit, scientific research consortium that monitors the safety and effectiveness of biosimilars and corresponding novel biologics and provides the assurance needed to determine which medications deliver the best health outcomes.
Current research: Oncology data fitness and descriptive analysis. The consortium will evaluate the current data capabilities of the BBCIC distributed research networks and identify additional data sources to enrich BBCIC capabilities in measures relevant to oncology outcome.
